Erick Lucera - 18 Sep 2023 Form 4 Insider Report for Bone Biologics Corp (BBLG)

Reporting relationship
Director
Issuer ticker
BBLG
Reported as of
18 Sep 2023
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Sep 2023, 14:54:16 UTC
Prior SEC filing
18 May 2023
Next SEC filing
05 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Erick Lucera

Key filing fact

Erick Lucera filed Form 4 for Bone Biologics Corp (BBLG) on 20 Sep 2023.

Key facts

  • This page summarizes Erick Lucera's Form 4 filing for Bone Biologics Corp (BBLG).
  • 1 reported transaction and 5 derivative rows are listed below.
  • Accepted by SEC: 20 Sep 2023, 14:54.

Change

  • Previous filing in this sequence was filed on 18 May 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BBLG transaction Derivative

Non-Employee Stock Option

Award

Transaction value
$0
Shares
+85,763
Change %
Price
$0.000000
Shares after
85,763
Date
18 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
85,763
Exercise price
$0.6400
Footnotes
F1
BBLG holding Derivative

Non-Employee Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,229
Date
18 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,229
Exercise price
$48.41
Footnotes
F2
BBLG holding Derivative

Non-Employee Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
291
Date
18 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
291
Exercise price
$105.60
Footnotes
F2
BBLG holding Derivative

Non-Employee Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
99
Date
18 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
99
Exercise price
$157.50
Footnotes
F2
BBLG holding Derivative

Non-Employee Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
677
Date
18 Sep 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
667
Exercise price
$157.50
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Vests quarterly through the date of the next annual meeting of the stockholders of the Company following the Grant.

Footnote F2

This option is fully vested as of the date of this report.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .